Literature DB >> 24781042

The etiology of occupational pulmonary aluminosis--the past and the present.

Petra Smolkova1, Marie Nakladalova.   

Abstract

BACKGROUND: The authors review pulmonary aluminosis caused by exposure to dust containing aluminium and its compounds, mainly oxides. Special attention is paid to various factors of occupational exposure as to an important etiologic issue. The condition has a rich and interesting history dating back to the 1930s. The most significant occupational exposures are associated with processes in bauxite smelting, the use of fine aluminium powder, exposure to aluminium welding fumes, grinding and polishing of aluminium materials. METHODS AND
RESULTS: A literature search for relevant scientific studies in English was performed using the following internet databases: relevant sections of The Cochrane Library, EBSCO Discovery Service, Ovid, ProQuest Science Journals, PubMed, ScienceDirect, Scopus and Web of Knowledge. The initial clinical manifestations of pulmonary aluminosis are exertional dyspnea with dry, non-productive cough. Depending on the type and length of the occupational exposure, ventilatory defects may vary considerably from restrictive to obstructive pattern. Radiographic findings commonly showing nodular or slightly irregular opacities are predominantly located in the upper, less frequently in the lower lung fields, or can have a diffuse pattern. In advanced stages, severe pulmonary fibrosis with honeycombing occured.
CONCLUSIONS: Although pulmonary aluminosis is a very rare disease, it still occurs. Since the industrial importance and use of aluminium continue to rise, lung damage from exposure to respirable aluminium particles should not be overlooked but monitored and prevented. Even today, the pathophysiology of pulmonary aluminosis has not been explained as yet.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24781042     DOI: 10.5507/bp.2014.017

Source DB:  PubMed          Journal:  Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub        ISSN: 1213-8118            Impact factor:   1.245


  5 in total

1.  Elemental and immunohistochemical analysis of the lungs and hilar lymph node in a patient with asbestos exposure, a pilot study.

Authors:  Yasuhiko Koga; Takahiro Satoh; Kyoichi Kaira; Masashi Koka; Takeshi Hisada; Junko Hirato; Bolag Altan; Masakiyo Yatomi; Akihiro Ono; Yosuke Kamide; Yasuo Shimizu; Haruka Aoki-Saito; Hiroaki Tsurumaki; Kimihiro Shimizu; Akira Mogi; Tamotsu Ishizuka; Masanobu Yamada; Kunio Dobashi
Journal:  Environ Health Prev Med       Date:  2016-10-03       Impact factor: 3.674

2.  Mixed-dust pneumoconiosis in a dental technician: a multidisciplinary diagnosis case report.

Authors:  Luigi Di Lorenzo; Francesco Inchingolo; Antonella Pipoli; Antonio Di Lorenzo; Alessio Danilo Inchingolo; Gianna Dipalma; Filippo Cassano; Maria Elena Maggiore; Angelo Michele Inchingolo; Sabino Ceci; Assunta Patano; Giuseppina Malcangi; Antonio Mancini; Giosi Longo; Rossella Attimonelli; Eugenio Maiorano; Rocco Laviano; Nicola Mariano Manghisi; Antonio Scarano; Felice Lorusso
Journal:  BMC Pulm Med       Date:  2022-04-27       Impact factor: 3.320

3.  A case of airway aluminosis with likely secondary pleuroparenchymal fibroelastosis.

Authors:  Yuki Yabuuchi; Hitomi Goto; Mizu Nonaka; Hiroaki Tachi; Tatsuya Akiyama; Naoki Arai; Hiroaki Ishikawa; Kentaro Hyodo; Kenji Nemoto; Yukiko Miura; Isano Hase; Shuji Oh-Ishi; Kenji Hayashihara; Takefumi Saito; Tatsuya Chonan
Journal:  Multidiscip Respir Med       Date:  2019-04-15

4.  Pneumoconiosis Caused by Inhalation of Metallic Titanium Grindings.

Authors:  Yuki Iijima; Tomoya Tateishi; Kimitake Tsuchiya; Yuki Sumi; Takumi Akashi; Yasunari Miyazaki
Journal:  Intern Med       Date:  2019-10-24       Impact factor: 1.271

5.  Elemental analysis of occupational granulomatous lung disease by electron probe microanalyzer with wavelength dispersive spectrometer: Two case reports.

Authors:  Hiromi Tomioka; Toshihiko Kaneda; Eiji Katsuyama; Masanori Kitaichi; Hiroshi Moriyama; Eiichi Suzuki
Journal:  Respir Med Case Rep       Date:  2016-04-26
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.